Hints and tips:
Related Special Reports
...This month Brazil started distributing a vaccine produced by Japanese pharmaceutical group Takeda....
...Pfizer, the pharmaceutical group, is challenging an Oregon shareholder proposal at the SEC. The company declined to comment....
...Tensions between Washington and Beijing are also spiking again, this time over the ongoing tour of the Americas by Taiwan’s president Tsai Ing-wen....
...The head of Asia’s largest pharmaceutical company said the era of globalisation based on outsourcing functions to cut costs was over....
...He is treating patients including Bennett with an experimental compound called KPL-404 which Kiniksa Pharmaceuticals is developing as a treatment for autoimmune diseases....
...Seeing the business opportunity in this fast-growing area, Piedmont Lithium, a mining company originally incorporated in Australia, began knocking on the doors of the old houses surrounding a roughly 3,000...
...But how good is corporate America’s record on following such pledges with concrete changes?...
...It started in 2019 with 150 randomly picked citizens (yes, really) who chose to give feedback that was incorporated into the legislation. The effort is not without controversy....
...Investors are upbeat about the company’s acquisition of a business previously owned by Japanese rival Takeda, and a touted merger of three Celltrion affiliates. Song Jung-a 64....
...Brown’s Blossom Capital, which has also backed fast-growing online payments company Checkout.com, joined Dija’s £20m fundraising last year before the company had even been incorporated, partly on the strength...
...Both Takeda, the Japanese pharmaceutical company, and Regeneron, the New York-based biotech, have been trying to identify the most robust antibodies from recovered patients....
...Fresnillo, the world’s biggest silver miner and part of Mexico’s Grupo Bal, has also paid just over $205m in taxes, according to a regulatory filing in the UK, where it is incorporated....
...Although 2019 did not have a mega-deal to match Takeda Pharmaceutical’s $62bn purchase of Shire, which was announced in 2018, there was a steady increase in both the number and size of deals as more sectors...
...“Serenity, discipline and collaboration, values that every Cuban has incorporated, can prevent the spread of the virus,” he added....
...Investors are upbeat about its acquisition of a unit carved off by Japanese rival Takeda, and a touted merger of three Celltrion affiliates. Edward White 73....
...in Europe, Latin America and Africa....
...Now, Takeda Pharmaceutical will hold an extraordinary general meeting this week, and it's sure to be closely watched....
...The technology, developed over 10 years by Silicon Valley-based Proteus Digital Health, will be incorporated into an existing antipsychotic drug, Abilify, made by Japanese drugmaker Otsuka Pharmaceutical...
...biggest pharmaceutical companies....
...Three questions Sarah Neville spoke to Christophe Weber, CEO of Takeda Pharmaceutical, which has just bought Shire, the rare diseases specialist....
...(FT) A nod for Japan’s largest corporate takeover Takeda Pharmaceutical won important shareholder approval to finance its £46bn takeover of Ireland’s Shire....
...The latest acquisition contributes to a record year for Japanese outbound deals, led by Takeda Pharmaceutical’s £46bn agreement to buy Irish drugmaker Shire in April....
...Others focused on the significance of Takeda’s move for its country’s pharmaceuticals industry....
...Shire shareholders will have final say on Takeda deal After days of “will they, won’t they”, the verdict finally arrived early on Wednesday: Japan’s Takeda had, on the fifth try, made an offer for Shire...
...GSK said, however, that its new shingles medicine Shingrix had performed well, notching up sales of £110m in North America, against consensus expectations of £40m....
International Edition